Vigabatrin and Insulin Sensitivity
Conditions:   NAFLD;   Obesity Interventions:   Drug: Vigabatrin;   Drug: Placebo oral tablet Sponsor:   Washington University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2020 Category: Research Source Type: clinical trials

Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions:   Gestational Diabetes;   Other  " Heavy-For-Dates "  Infants;   Small for Gestational Age Infant;   Diabetes Mellitus, Type 2 Intervention:   Diagnostic Test: meal tolerance test Sponsor:   University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions:   Insulin Resistance;   Non-Alcoholic Fatty Liver Disease Interventions:   Drug: Curcumin Liposome;   Drug: Prednisolone;   Drug: Placebos Sponsor:   University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions:   Hypercholesterolemia;   Insulin Resistance;   Insulin Secretion Intervention:   Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor:   University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions:   Gestational Diabetes;   Other  " Heavy-For-Dates "  Infants;   Small for Gestational Age Infant;   Diabetes Mellitus, Type 2 Intervention:   Diagnostic Test: meal tolerance test Sponsor:   University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions:   Insulin Resistance;   Non-Alcoholic Fatty Liver Disease Interventions:   Drug: Curcumin Liposome;   Drug: Prednisolone;   Drug: Placebos Sponsor:   University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions:   Hypercholesterolemia;   Insulin Resistance;   Insulin Secretion Intervention:   Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor:   University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions:   Gestational Diabetes;   Other  " Heavy-For-Dates "  Infants;   Small for Gestational Age Infant;   Diabetes Mellitus, Type 2 Intervention:   Diagnostic Test: meal tolerance test Sponsor:   University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions:   Insulin Resistance;   Non-Alcoholic Fatty Liver Disease Interventions:   Drug: Curcumin Liposome;   Drug: Prednisolone;   Drug: Placebos Sponsor:   University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions:   Hypercholesterolemia;   Insulin Resistance;   Insulin Secretion Intervention:   Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor:   University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions:   Gestational Diabetes;   Other  " Heavy-For-Dates "  Infants;   Small for Gestational Age Infant;   Diabetes Mellitus, Type 2 Intervention:   Diagnostic Test: meal tolerance test Sponsor:   University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions:   Insulin Resistance;   Non-Alcoholic Fatty Liver Disease Interventions:   Drug: Curcumin Liposome;   Drug: Prednisolone;   Drug: Placebos Sponsor:   University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions:   Hypercholesterolemia;   Insulin Resistance;   Insulin Secretion Intervention:   Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor:   University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions:   Gestational Diabetes;   Other  " Heavy-For-Dates "  Infants;   Small for Gestational Age Infant;   Diabetes Mellitus, Type 2 Intervention:   Diagnostic Test: meal tolerance test Sponsor:   University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions:   Insulin Resistance;   Non-Alcoholic Fatty Liver Disease Interventions:   Drug: Curcumin Liposome;   Drug: Prednisolone;   Drug: Placebos Sponsor:   University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions:   Hypercholesterolemia;   Insulin Resistance;   Insulin Secretion Intervention:   Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor:   University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions:   Gestational Diabetes;   Other  " Heavy-For-Dates "  Infants;   Small for Gestational Age Infant;   Diabetes Mellitus, Type 2 Intervention:   Diagnostic Test: meal tolerance test Sponsor:   University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions:   Insulin Resistance;   Non-Alcoholic Fatty Liver Disease Interventions:   Drug: Curcumin Liposome;   Drug: Prednisolone;   Drug: Placebos Sponsor:   University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions:   Hypercholesterolemia;   Insulin Resistance;   Insulin Secretion Intervention:   Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor:   University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions:   Gestational Diabetes;   Other  " Heavy-For-Dates "  Infants;   Small for Gestational Age Infant;   Diabetes Mellitus, Type 2 Intervention:   Diagnostic Test: meal tolerance test Sponsor:   University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions:   Insulin Resistance;   Non-Alcoholic Fatty Liver Disease Interventions:   Drug: Curcumin Liposome;   Drug: Prednisolone;   Drug: Placebos Sponsor:   University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions:   Hypercholesterolemia;   Insulin Resistance;   Insulin Secretion Intervention:   Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor:   University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions:   Gestational Diabetes;   Other  " Heavy-For-Dates "  Infants;   Small for Gestational Age Infant;   Diabetes Mellitus, Type 2 Intervention:   Diagnostic Test: meal tolerance test Sponsor:   University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions:   Insulin Resistance;   Non-Alcoholic Fatty Liver Disease Interventions:   Drug: Curcumin Liposome;   Drug: Prednisolone;   Drug: Placebos Sponsor:   University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions:   Hypercholesterolemia;   Insulin Resistance;   Insulin Secretion Intervention:   Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor:   University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions:   Gestational Diabetes;   Other  " Heavy-For-Dates "  Infants;   Small for Gestational Age Infant;   Diabetes Mellitus, Type 2 Intervention:   Diagnostic Test: meal tolerance test Sponsor:   University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions:   Insulin Resistance;   Non-Alcoholic Fatty Liver Disease Interventions:   Drug: Curcumin Liposome;   Drug: Prednisolone;   Drug: Placebos Sponsor:   University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions:   Hypercholesterolemia;   Insulin Resistance;   Insulin Secretion Intervention:   Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor:   University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions:   Gestational Diabetes;   Other  " Heavy-For-Dates "  Infants;   Small for Gestational Age Infant;   Diabetes Mellitus, Type 2 Intervention:   Diagnostic Test: meal tolerance test Sponsor:   University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions:   Insulin Resistance;   Non-Alcoholic Fatty Liver Disease Interventions:   Drug: Curcumin Liposome;   Drug: Prednisolone;   Drug: Placebos Sponsor:   University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions:   Hypercholesterolemia;   Insulin Resistance;   Insulin Secretion Intervention:   Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor:   University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions:   Gestational Diabetes;   Other  " Heavy-For-Dates "  Infants;   Small for Gestational Age Infant;   Diabetes Mellitus, Type 2 Intervention:   Diagnostic Test: meal tolerance test Sponsor:   University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions:   Insulin Resistance;   Non-Alcoholic Fatty Liver Disease Interventions:   Drug: Curcumin Liposome;   Drug: Prednisolone;   Drug: Placebos Sponsor:   University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Effect of Serum LDL Cholesterol Concentration on Pancreatic Insulin Secretion
Conditions:   Hypercholesterolemia;   Insulin Resistance;   Insulin Secretion Intervention:   Drug: Lowering cholesterol concentrations by PCSK-9 inhibitor Sponsor:   University Hospital Tuebingen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions:   Gestational Diabetes;   Other  " Heavy-For-Dates "  Infants;   Small for Gestational Age Infant;   Diabetes Mellitus, Type 2 Intervention:   Diagnostic Test: meal tolerance test Sponsor:   University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions:   Insulin Resistance;   Non-Alcoholic Fatty Liver Disease Interventions:   Drug: Curcumin Liposome;   Drug: Prednisolone;   Drug: Placebos Sponsor:   University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Pregnancy Outcomes and Maternal Insulin Sensitivity
Conditions:   Gestational Diabetes;   Other  " Heavy-For-Dates "  Infants;   Small for Gestational Age Infant;   Diabetes Mellitus, Type 2 Intervention:   Diagnostic Test: meal tolerance test Sponsor:   University Medical Center Groningen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

The Effect of Curcumin on the Development of Prednisolone-induced Hepatic Insulin Resistance
Conditions:   Insulin Resistance;   Non-Alcoholic Fatty Liver Disease Interventions:   Drug: Curcumin Liposome;   Drug: Prednisolone;   Drug: Placebos Sponsor:   University Hospital, Gentofte, Copenhagen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 19, 2020 Category: Research Source Type: clinical trials

Studying the Effect of Mediterranean Diet on Insulin Resistance Among Obese Children and Adolescents
Conditions:   Obesity, Childhood;   Insulin Resistance Intervention:   Other: the effect of Mediterranean diet on insulin sensitivity among obese children and adolescents aged Sponsor:   University of Jordan Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 18, 2020 Category: Research Source Type: clinical trials